Skip to main content
  • Book
  • © 2009

Principles of Cancer Biotherapy

  • Comprehensive focus on biological therapy for cancer
  • Multiple expert authors

Buy it now

Buying options

eBook USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (31 chapters)

  1. Front Matter

    Pages i-xi
  2. Cancer biotherapy: general principles

    • Robert K. Oldham
    Pages 1-16
  3. The pathogenesis of cancer metastasis: relevance to therapy

    • Sun-Jin Kim, Cheryl Hunt Baker, Yasuhiko Kitadai, Toru Nakamura, Toshio Kuwai, Takamitsu Sasaki et al.
    Pages 17-40
  4. Recombinant proteins and genomics in cancer therapy

    • Kapil Mehta, Bulent Ozpolat, Kishorchandra Gohil, Bharat B. Aggarwal
    Pages 53-83
  5. Current concepts in immunology

    • Robert K. Oldham
    Pages 85-99
  6. Cancer vaccines

    • Kenneth A. Foon, Malek M. Safa
    Pages 147-153
  7. Cytokines

    • Walter M. Lewko, Robert K. Oldham
    Pages 155-276
  8. Interferons: therapy for cancer

    • David Goldstein, Robert Jones, Richard V. Smalley, Ernest C. Borden
    Pages 277-301
  9. Monoclonal antibody therapy

    • Robert O. Dillman
    Pages 303-406
  10. Immunotoxins

    • Arthur E. Frankel, Jung-Hee Woo, David M. Neville
    Pages 407-449
  11. Drug Immunoconjugates

    • Malek Safa, Kenneth A. Foon, Robert K. Oldham
    Pages 451-462
  12. Targeted radionuclide therapy of cancer

    • John M. Pagel, Otto C. Boerman, Hazel B. Breitz, Ruby F. Meredith
    Pages 463-496
  13. Growth and differentiation factors as cancer therapeutics

    • Kapil Mehta, Robert K. Oldham, Bulent Ozpolat
    Pages 527-568
  14. Granulocyte colony-stimulating factor: biology and clinical potential

    • MaryAnn Foote, George Morstyn
    Pages 569-580
  15. Granulocyte-macrophage colony-stimulating factor

    • Maryann Foote, George Morstyn
    Pages 581-588
  16. Cancer gene therapy

    • Donald J. Buchsbaum, C. Ryan Miller, Lacey R. Mcnally, Sergey A. Kaliberov
    Pages 589-612

About this book

At the time of the first edition of Principles of Cancer Biotherapy in 1987, this book represented the first comprehensive textbook on biological therapy. In 1991, when the second edition was published, there was still some doubt on the part of many oncologists and cancer researchers as to the therapeutic value of these new approaches. By 2003 and the fourth edition, it was generally agreed that biopharmaceuticals were producing major opportunities for new cancer therapies. Cancer biotherapy has now truly matured into the fourth modality of cancer treatment. This fifth revised edition describes the tremendous progress that has been made in recent years using biologicals in cancer treatment.

This book summarizes an evolving science and a rapidly changing medical practice in biotherapy. In this new millennium, it is now possible to envision a much more diversified system of cancer research and treatment that will afford greater opportunities for a patient’s personalized cancer treatment. This was first envisioned in the 1987 initial edition of this textbook and is now a “new” and popular approach to cancer treatment. Some forms of cancer biotherapy use the strategy of tumor stabilization and control through continued biological therapy, akin to the use of insulin in the treatment of diabetes.

This textbook illustrates new methods of thinking and new strategies for control of cancer. It is always difficult to move from past dogma to future opportunity, but this fifth edition of Principles of Cancer Biotherapy illustrates why it is so important to the patients for researchers and clinicians to explore and quickly apply these new opportunities in cancer biotherapy.

Editors and Affiliations

  • Hematology-Oncology Associates of Southeast Missouri Hospital, Southeast Medical Plaza, Cape Girardeau, USA

    Robert K. Oldham

  • Hoag Cancer Center, Newport Beach, USA

    Robert O. Dillman

  • University of California, Irvine, USA

    Robert O. Dillman

Bibliographic Information

Buy it now

Buying options

eBook USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access